Utility and Limitations of Large Population-Based Data for Skin Cancer Outcomes
- PMID: 27772547
- DOI: 10.1016/j.jid.2016.07.031
Utility and Limitations of Large Population-Based Data for Skin Cancer Outcomes
Abstract
Large population-based studies are useful for determining cancer outcomes, but interpreting their findings requires understanding their limitations. Youlden et al. highlight the utility of using a large dataset for studying melanoma survival, whereas Gimotty et al. point out the limitations of such datasets in miscoding thickness, a key prognostic variable. Awareness of limitations of population-based registry data can help to inform their interpretations and clinical implications.
Copyright © 2016 The Author. Published by Elsevier Inc. All rights reserved.
Comment in
-
Response to Asgari.J Invest Dermatol. 2017 Apr;137(4):965-966. doi: 10.1016/j.jid.2016.12.003. Epub 2016 Dec 12. J Invest Dermatol. 2017. PMID: 27979725 No abstract available.
Comment on
-
Ten-Year Survival after Multiple Invasive Melanomas Is Worse than after a Single Melanoma: a Population-Based Study.J Invest Dermatol. 2016 Nov;136(11):2270-2276. doi: 10.1016/j.jid.2016.03.014. Epub 2016 Mar 24. J Invest Dermatol. 2016. PMID: 27019458
-
Miscoding of Melanoma Thickness in SEER: Research and Clinical Implications.J Invest Dermatol. 2016 Nov;136(11):2168-2172. doi: 10.1016/j.jid.2016.05.121. Epub 2016 Jun 25. J Invest Dermatol. 2016. PMID: 27354265 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical